Key Metrics
CiteScore 

3.8
H-Index 

56
Impact Factor 

< 5
SJR 

Q2Organic Chemistry

SNIP 

0.77
Recommended pre-submission checks
Powered by 

Topics Covered on Medicinal Chemistry Research
Medicinal Chemistry Research Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | SPRINGER BIRKHAUSER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Medicinal Chemistry Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Medicinal Chemistry Research
Small-molecule ferroptosis inducers and sensitizers in anticancer drug discovery: medicinal chemistry, structure-activity relationships, and translational perspectives.
- 24 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Azole chroman-4-one, tetralone and chromen-4-one derivatives: synthesis, Mycobacterium tuberculosis CYP121A1 enzyme inhibition and antimycobacterial activity.
- 23 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Structure-based discovery of acridone alkaloids as disruptors of the HEG1-KRIT1 protein-protein interaction in cerebral cavernous malformation signaling.
- 13 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Coumarin scaffolds in breast cancer research: derivatives, hybrids, and therapeutic potential.
- 13 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Bicyclononane-2,8-bis(trifluoromethyl)quinoline hybrids: synthesis, antiplasmodial and antitrypanosomal activity.
- 6 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation.
- 1 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Small-molecule ferroptosis inducers and sensitizers in anticancer drug discovery: medicinal chemistry, structure-activity relationships, and translational perspectives.
- 24 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Azole chroman-4-one, tetralone and chromen-4-one derivatives: synthesis, Mycobacterium tuberculosis CYP121A1 enzyme inhibition and antimycobacterial activity.
- 23 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Structure-based discovery of acridone alkaloids as disruptors of the HEG1-KRIT1 protein-protein interaction in cerebral cavernous malformation signaling.
- 13 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Coumarin scaffolds in breast cancer research: derivatives, hybrids, and therapeutic potential.
- 13 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Bicyclononane-2,8-bis(trifluoromethyl)quinoline hybrids: synthesis, antiplasmodial and antitrypanosomal activity.
- 6 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation.
- 1 Oct 2026
- Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents